SpringWorks Therapeutics

Bain-backed Beeline buzzes out of stealth with $300M

Beeline’s hive is led by Saqib Islam, who formerly led Pfizer-spinout SpringWorks through its two FDA approvals and $3.9 billion buyout by Merck KGaA.

Darren Incorvaia Apr 15, 2026 7:00am

Merck KGaA drops pipeline asset from SpringWorks buyout

Mar 5, 2026 4:33pm

Immunome's desmoid tumor treatment triumphs in phase 3

Dec 15, 2025 10:42am

Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders

Feb 9, 2024 9:30am

pay deal hand over cash licensing transaction money

Immunome pays $50M for Ayala's phase 3 desmoid tumor drug

Feb 6, 2024 9:50am

spring slinky competition overtake crush absorb

SpringWorks eyes AstraZeneca's Koselugo market with phase 2 data

Nov 16, 2023 10:59am